Drug Type Small molecule drug |
Synonyms Longacting progestin(VaRi Bioscience), VR101 |
Target |
Mechanism PR agonists(Progesterone receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pregnancy | Phase 2 | DE | 05 Feb 2023 |